XML 56 R42.htm IDEA: XBRL DOCUMENT v3.4.0.3
Other (Income)/Deductions - Net (Footnotes) (Details) - USD ($)
$ in Millions
3 Months Ended
Apr. 03, 2016
Mar. 29, 2015
Loss Contingencies [Line Items]    
Gain on sale of investments   $ 120
Income from contract resolution $ 116  
Distribution Rights [Member]    
Loss Contingencies [Line Items]    
Gain (loss) on disposition of intangible assets $ 16 $ 45
Hisun Pfizer Pharmaceuticals Co. Ltd [Member]    
Loss Contingencies [Line Items]    
Equity method investment, ownership percentage 49.00%  
Laboratorio Teuto Brasilero [Member]    
Loss Contingencies [Line Items]    
Equity method investment, ownership percentage 40.00%  
Other Nonoperating Income (Expense) [Member] | Hisun Pfizer Pharmaceuticals Co. Ltd [Member]    
Loss Contingencies [Line Items]    
Equity method investment, impairment $ 81  
Other Nonoperating Income (Expense) [Member] | Laboratorio Teuto Brasilero [Member]    
Loss Contingencies [Line Items]    
Equity method investment, impairment $ 50